Ken Griffin’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.3M Sell
109,867
-206,401
-65% -$50.5M ﹤0.01% 2095
2025
Q4
$80.2M Buy
316,268
+109,968
+53% +$27.6M 0.01% 1017
2025
Q3
$51M Buy
206,300
+101,939
+98% +$24.4M 0.01% 1357
2025
Q2
$25.1M Buy
104,361
+102,399
+5,219% +$23.8M ﹤0.01% 1890
2025
Q1
$445K Sell
1,962
-3,248
-62% -$714K ﹤0.01% 8734
2024
Q4
$1.07M Buy
5,210
+4,875
+1,455% +$1.07M ﹤0.01% 6869
2024
Q3
$81.3K Sell
335
-219,166
-100% -$51.3M ﹤0.01% 11391
2024
Q2
$48.2M Buy
+219,501
New +$47.7M 0.01% 1181
2024
Q1
Sell
-11,001
Closed -$2.48M 15404
2023
Q4
$2.42M Sell
11,001
-102,377
-90% -$21.7M ﹤0.01% 5030
2023
Q3
$24.9M Buy
113,378
+94,469
+500% +$21.4M 0.01% 1647
2023
Q2
$4.25M Buy
18,909
+17,079
+933% +$3.42M ﹤0.01% 3900
2023
Q1
$350K Sell
1,830
-2,049
-53% -$396K ﹤0.01% 9052
2022
Q4
$716K Sell
3,879
-98,998
-96% -$17.4M ﹤0.01% 7491
2022
Q3
$17.1M Sell
102,877
-39,701
-28% -$8.08M ﹤0.01% 2054
2022
Q2
$29.4M Sell
142,578
-120,008
-46% -$27.1M 0.01% 1483
2022
Q1
$63.5M Sell
262,586
-22,081
-8% -$5.12M 0.01% 946
2021
Q4
$69.3M Buy
284,667
+208,766
+275% +$47.7M 0.01% 921
2021
Q3
$15.5M Sell
75,901
-202,009
-73% -$43.2M ﹤0.01% 2384
2021
Q2
$57.3M Buy
277,910
+243,759
+714% +$49.1M 0.01% 1028
2021
Q1
$6.5M Buy
34,151
+17,166
+101% +$3.18M ﹤0.01% 3735
2020
Q4
$3.22M Sell
16,985
-3,188
-16% -$595K ﹤0.01% 4473
2020
Q3
$3.55M Buy
20,173
+14,734
+271% +$2.36M ﹤0.01% 3686
2020
Q2
$835K Buy
+5,439
New +$828K ﹤0.01% 6167
2020
Q1
Sell
-124,630
Closed -$18.6M 10145
2019
Q4
$19M Sell
124,630
-65,732
-35% -$9.63M 0.01% 1533
2019
Q3
$27.5M Buy
190,362
+91,978
+93% +$13.7M 0.01% 1207
2019
Q2
$14.6M Buy
98,384
+84,991
+635% +$11.4M 0.01% 1729
2019
Q1
$1.72M Sell
13,393
-137,592
-91% -$16.2M ﹤0.01% 4723
2018
Q4
$16.1M Buy
150,985
+123,466
+449% +$13.8M 0.01% 1406
2018
Q3
$3.15M Sell
27,519
-1,504
-5% -$170K ﹤0.01% 3651
2018
Q2
$3.05M Buy
29,023
+24,005
+478% +$2.41M ﹤0.01% 3453
2018
Q1
$468K Sell
5,018
-232,194
-98% -$21.1M ﹤0.01% 5985
2017
Q4
$20.7M Sell
237,212
-75,488
-24% -$6.73M 0.01% 1134
2017
Q3
$27.6M Buy
312,700
+234,996
+302% +$19.9M 0.02% 879
2017
Q2
$6.33M Buy
77,704
+11,808
+18% +$898K 0.01% 1871
2017
Q1
$4.58M Buy
65,896
+20,207
+44% +$1.4M ﹤0.01% 2139
2016
Q4
$3.08M Sell
45,689
-279,305
-86% -$18.9M ﹤0.01% 2473
2016
Q3
$23.8M Buy
324,994
+176,390
+119% +$12.5M 0.02% 770
2016
Q2
$10.2M Buy
148,604
+19,524
+15% +$1.37M 0.01% 1225
2016
Q1
$9.17M Buy
129,080
+122,314
+1,808% +$8.27M 0.01% 1262
2015
Q4
$510K Sell
6,766
-39,197
-85% -$2.83M ﹤0.01% 4447
2015
Q3
$2.99M Buy
45,963
+44,074
+2,333% +$2.91M ﹤0.01% 2471
2015
Q2
$122K Sell
1,889
-18,096
-91% -$1.22M ﹤0.01% 6885
2015
Q1
$1.4M Sell
19,985
-102,200
-84% -$6.74M ﹤0.01% 3519
2014
Q4
$7.92M Sell
122,185
-328,543
-73% -$20.3M 0.01% 1582
2014
Q3
$24.3M Buy
450,728
+37,720
+9% +$2.05M 0.03% 799
2014
Q2
$22.1M Sell
413,008
-341,437
-45% -$17.6M 0.03% 749
2014
Q1
$36M Buy
754,445
+737,039
+4,234% +$34.5M 0.04% 534
2013
Q4
$836K Sell
17,406
-70,958
-80% -$3.24M ﹤0.01% 3402
2013
Q3
$3.8M Sell
88,364
-190,726
-68% -$8.29M 0.01% 1806
2013
Q2
$12M Buy
+279,090
New +$12M 0.02% 955

Other funds holding STE

Ken Griffin's STE Position: Q1 2026 in Review

Ken Griffin reduced its Steris (STE) stake by 65% in Q1 2026, selling an estimated $50.5M and leaving 109,867 shares worth $24.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2095.

Ken Griffin first reported a position in STE in Q2 2013 and has held it in 50 quarters since. The position peaked at $80.2M in Q4 2025. 843 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Ken Griffin held 109,867 shares of Steris worth $24.3M as of Q1 2026.
  • Ken Griffin sold 206,401 Steris shares in Q1 2026, an estimated $50.5M.
  • Steris made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #2095 holding.
  • Ken Griffin first reported a position in Steris in Q2 2013 and has held it in 50 quarters since.
  • Ken Griffin's Steris position peaked at $80.2M in Q4 2025.
  • 843 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.